{
    "2020-06-17": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Lilly Stock Has a 10% Upside, Guggenheim Says",
                "features": {
                    "keywords": [
                        "Lilly",
                        "stock",
                        "upside",
                        "Guggenheim"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Novartis' (NVS) Cosentyx Gets FDA Nod for New Indication",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Cosentyx",
                        "FDA",
                        "nod",
                        "indication"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "The Daily Biotech Pulse: Patent Win For Amarin, FDA Nod For Novartis & Merck, Chembio's Coronavirus EUA Revoked",
                "features": {
                    "keywords": [
                        "biotech",
                        "patent",
                        "win",
                        "Amarin",
                        "FDA",
                        "nod",
                        "Novartis",
                        "Merck",
                        "Chembio",
                        "coronavirus",
                        "EUA",
                        "revoked"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "mixed",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Novartis Scores FDA Ilaris Approval For Rare Type Of Arthritis",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Ilaris",
                        "FDA",
                        "approval",
                        "arthritis"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}